Responses
Clinical/translational cancer immunotherapy
Original research
Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies
Compose a Response to This Article
Other responses
No responses have been published for this article.